MLEC
Moolec ScienceAAI scenario view
RankAlpha Sentiment CodexAI sentiment snapshot
AI commentary
Primary-source evidence is better than the packet alone, but the stock still reads as a cautious monitoring name rather than a conviction setup. The May 13, 2026 filing indicates Nasdaq stockholders' equity compliance was addressed, yet the same filing shows only about $1.2m cash versus roughly $93.4m of liabilities, so the balance sheet remains thin even after remediation [#6K-2026-05-13]. The April 2, 2026 6-K confirms AIGC's 65.1% control [#6K-2026-04-02], and the June 17, 2025 business combination created a broader platform [#PR-2025-06-17], but there is still no analyst revision signal or clear evidence of durable commercial conversion. No social coverage was provided, so sentiment and buzz should be treated as effectively unavailable rather than bullish.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
On May 13, 2026, Moolec said it submitted the information needed to demonstrate compliance with Nasdaq Capital Market stockholders' equity requirements within the Panel's remediation period; the same filing showed stockholders' equity of about $15.2m at March 31, 2026 versus $11.3m at December 31, 2025 [#6K-2026-05-13].
The April 2, 2026 6-K says Agriculture Investment Group Corp. became Moolec's controlling shareholder with 65.1% of outstanding shares after a partial preference-share conversion, and management said it expects to notify conversion of the remaining $4.0m within the next 12 months [#6K-2026-04-02].
The June 17, 2025 business-combination close expanded Moolec across food ingredients, ag-biologicals, precision fermentation, biomaterials, and R&D services, but the investment case still depends on turning that broader platform into repeatable revenue rather than a larger story alone [#PR-2025-06-17].
Recommendation
No formal recommendation provided.

